Drug InformationPharmacy FAQWhat does the term "generic" mean? Do generic medications produce the same effect that the brand name medicines do?The difference between a brand name medicine and a generic one is in the name, shape and in the price. A generic drug is u... more >> Why are generic medicines so cheap?Unlike generic drugs, a large part of the costs incurred by original manufacturers of brand name drugs are for research and development and advertising. The expense of obtaining FDA approval alone in th... more >> Pills do not look like the brand name medication. The pills have a different name printed on them. Why?As we have already mentioned that no manufacturer can take out a patent for a chemical agent. Thus generics can have the exactly same... more >> Does every brand-name drug have a generic equivalent?No. About half of all prescription drugs have generic equivalents at this time. Generics can be manufactured only after patents on brand-name drugs have expired. There will be generic ... more >> When can a generic drug be producedGeneric drugs can be legally produced for drugs where: 1) the patent has expired, 2) the generic company certifies the brand company's patents are either invalid, unenforceable or will not be infringed,... more >> That is online pharmacy?Since about the year 2000, hundreds of pharmacies have begun operating over the internet. |
special offers
Losartan potassium and HydrochlorothiazideGeneric name: Losartan potassium and Hydrochlorothiazide Why is Losartan potassium and Hydrochlorothiazide prescribed?Hyzaar is a combination medication used in the treatment of high blood pressure. One component, losartan, belongs to a new class of blood pressure medications that work by preventing the hormone angiotensin II from constricting the blood vessels, thus allowing blood to flow more freely and keeping the blood pressure down. The other component, hydrochlorothiazide, is a diuretic that increases the output of urine, removing excess fluid from the body and thus lowering blood pressure. Most important fact about Losartan potassium and HydrochlorothiazideYou must take Hyzaar regularly for it to be effective. Since blood pressure declines gradually, it may be several weeks before you get the full benefit of Hyzaar, and you must continue taking it even if you are feeling well. Hyzaar does not cure high blood pressure; it merely keeps it under control. How should you take Losartan potassium and Hydrochlorothiazide?Hyzaar may be taken with or without food. Take Hyzaar exactly as directed. Try to take it at the same time each day so that it is easier to remember. --If you miss a dose... Take the forgotten dose as soon as you remember. If it is almost time for your next dose, skip the one you missed and go back to your regular schedule. --Storage instructions... Keep in a tightly closed container at room temperature. Protect from light. What side effects may occur?Side effects cannot be anticipated. If any develop or change in intensity, inform your doctor as soon as possible. Only your doctor can determine if it is safe for you to continue taking Hyzaar.
Why should Losartan potassium and Hydrochlorothiazide not be prescribed?If you have ever had an allergic reaction to losartan, hydrochlorothiazide, or sulfa drugs, you should not take Losartan potassium and Hydrochlorothiazide. If you are unable to urinate, do not take Hyzaar. Special warnings about Losartan potassium and HydrochlorothiazideIf you are taking Hyzaar and have kidney disease, your doctor will watch your kidney function carefully. Hyzaar can cause low blood pressure, especially if you are also taking another diuretic. You may feel light-headed or faint, especially during the first few days of therapy. If these symptoms occur, contact your doctor. Your dosage may need to be adjusted or discontinued. If you actually faint, stop taking the medication until you have talked to your doctor. If you have liver or kidney disease, diabetes, gout, or lupus erythematosus, Hyzaar should be used with caution. This drug may bring out hidden diabetes. If you are already taking insulin or oral diabetes drugs, your medication may have to be adjusted. If you have bronchial asthma or a history of allergies, you may be at greater risk for an allergic reaction to Losartan potassium and Hydrochlorothiazide. Excessive sweating, severe diarrhea or vomiting could deplete your body fluids and cause your blood pressure to drop too low. Be careful when exercising and in hot weather. Call your doctor if your mouth becomes dry, you feel weak or tired or sluggish, you are unusually thirsty, you feel restless or confused, you ache all over, your heart starts beating faster, or you are nauseated. Rare but serious allergic reactions to Hyzaar have been reported. If you develop swelling of the face, lips, or throat, call your doctor immediately. Serious swelling could obstruct your breathing. Possible food and drug interactions when taking Losartan potassium and HydrochlorothiazideHyzaar may increase the effects of alcohol. Avoid alcohol while taking Losartan potassium and Hydrochlorothiazide. If Hyzaar is taken with certain other drugs, the effects of either could be increased, decreased, or altered. It is especially important to check with your doctor before taking Hyzaar with the following: Special information if you are pregnant or breastfeedingWhen used in the second or third trimester of pregnancy, Hyzaar can cause injury or even death to the unborn child. Stop taking Hyzaar as soon as you know you are pregnant. If you are pregnant or plan to become pregnant, tell your doctor immediately. Hyzaar appears in breast milk and can affect the nursing infant. If Losartan potassium and Hydrochlorothiazide is essential to your health, your doctor may advise you to stop breastfeeding while you are taking Hyzaar. Recommended dosageADULTS Hyzaar comes in two strengths, 50-12.5 (50 milligrams of losartan and 12.5 milligrams of hydrochlorothiazide) and 100-25 (a double dose of each component). The usual starting dose is one 50-12.5 tablet per day. If your blood pressure does not respond to this dose, after about 3 weeks the doctor may increase the dose to two 50-12.5 tablets once daily, or one 100-25 tablet a day. CHILDREN The safety and effectiveness of Hyzaar in children have not been studied. OverdosageAny medication taken in excess can have serious consequences. Information concerning Hyzaar overdosage is limited. However, extremely low blood pressure and abnormally rapid or slow heartbeat may be signs of an overdose. Other signs may include dryness and thirst, overall weakness and tiredness, restlessness and confusion, muscle pains, nausea, and vomiting. If you suspect an overdose, seek medical attention immediately. ![]() Consumer Information (PDR) |
Online PharmacyOnline PharmacyOnline PharmaciesRx Generic PharmacyAggregationMeds NewsNew Drug Shows Promise for Rheumatoid ArthriitisHealthDay - FRIDAY, June 26 (HealthDay News) -- A new drug to treat rheumatoid arthritis reduces joint inflammation in severe cases while causing only mild to moderate side effects, according to a report from the first clinical trial of the drug on humans... more >>Sun, 28 Jun 2009 Prescription drugs in spotlight after Jackson death (AFP)AFP - Michael Jackson's death has lifted a veil on the sinister underbelly of fame, with associates of the pop icon hitting out at celebrity-dazzled doctors who funnel powerful narcotics to the stars... more >>Sun, 28 Jun 2009 Clinical Trials Update: June 25, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:.. more >>Fri, 26 Jun 2009 Poison control at risk in California, other statesAP - Each day, skeleton crews of doctors, nurses and pharmacists field almost 900 calls a day around California from people such as a mother whose child swallowed flea repellant and an elderly man who accidentally doubled up on his medication... more >>Thu, 25 Jun 2009 Clinical Trials Update: June 24, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:.. more >>Thu, 25 Jun 2009 New Cancer Drug Fights Tumors in Those With BRCA MutationsHealthDay - WEDNESDAY, June 24 (HealthDay News) -- A new cancer drug called olaparib worked well in an early clinical trial against breast, ovarian and prostate cancers in individuals who were genetically vulnerable to developing these malignancies... more >>Thu, 25 Jun 2009 New drug therapies raise 'ethical concerns': EU centre (AFP)AFP - Scientific advances could help fight drug addiction but new invasive treatments such as inserting electrodes into the brain raise "ethical concerns," the EU's drug monitoring centre said Wednesday... more >>Wed, 24 Jun 2009 Clinical Trials Update: June 23, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:.. more >>Wed, 24 Jun 2009 Mozambique factory to sell HIV drugs by December: officials (AFP)AFP - A Brazilian-funded factory for producing anti-retroviral drugs, the first in Mozambique, will begin selling the key HIV medication by year's end, officials said Tuesday... more >>Tue, 23 Jun 2009 Drug deals cost U.S. consumers $3.5 bln a year: FTCReuters - Consumers, insurance companies and the federal government spend an extra $3.5 billion for prescription drugs every year because brand-name companies pay generic producers to stay out of the market, the head of the U.S. Federal Trade Commission said on Tuesday... more >>Tue, 23 Jun 2009 Clinical Trials Update: June 22, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:.. more >>Tue, 23 Jun 2009 Promising Therapy for Prostate CancerHealthDay - MONDAY, June 22 (HealthDay News) -- An experimental drug therapy appears to have helped destroy allegedly inoperable prostate cancer in two patients in a clinical trial... more >>Tue, 23 Jun 2009 U.S. states say Wyeth failed to pay rebatesReuters - A coalition of 15 U.S. states filed a complaint in federal court charging that drugmaker Wyeth avoided paying millions of dollars of rebates to state Medicaid programs that had purchased its Protonix drugs, Massachusetts Attorney General Martha Coakley said on Monday... more >>Mon, 22 Jun 2009 Deal reached to cut drug costsReuters - Drug manufacturers will offer some $80 billion in prescription discounts for Medicare recipients under a deal unveiled on Saturday, which could boost President Barack Obama as he pushes to overhaul the $2.5 trillion U.S. healthcare system... more >>Sat, 20 Jun 2009 Health Tip: Life After a Heart AttackHealthDay - (HealthDay News) -- Life usually doesn't return to the way it was before a heart attack. You'll probably need to make changes to your daily way of life, including taking new medication... more >>Sat, 20 Jun 2009 Clinical Trials Update: June 19, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:.. more >>Sat, 20 Jun 2009 Program Helps 1st Graders Stay Safe Long-TermHealthDay - FRIDAY, June 19 (HealthDay News) -- A school-based prevention program begun in the early grades can reduce rates of substance abuse, violence and early sexual activity, says a U.S. study... more >>Sat, 20 Jun 2009 Make Nursing Homes More Like Home: MedicareHealthDay - FRIDAY, June 19 (HealthDay News) -- A warm, welcoming environment where residents are free to make choices regarding their care: That's the new vision of the ideal nursing home, according to a guidance issued Friday by the U.S. Centers for Medicare & Medicaid Services (CMS)... more >>Sat, 20 Jun 2009 Clinical Trials Update: June 18, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnetion.com and CenterWatch:.. more >>Fri, 19 Jun 2009 Teens of Dads Who Drink Too Much Tend to Follow SuitHealthDay - THURSDAY, June 18 (HealthDay News) -- Teen children who live with alcohol-abusing fathers are at higher risk for alcohol or drug abuse themselves, a U.S. government study released Thursday shows... more >>Fri, 19 Jun 2009 | |
|
losartan.org © 2007
Losartan Consumer Information MedFacts, Cerner Multum, Micromedex, PDR and Professional Monographs (FDA) | |||